Olivia Newton-John Cancer Wellness and Research Centre

OrgUnit's Researchers
(Persons)

Results 1-5 of 45 (Search time: 0.003 seconds).

FullnameTranslated NameEmail
Berlangieri, AlexandraAlexandra.BERLANGIERI@austin.org.au
Berlangieri, Salvatore USam.Berlangieri@austin.org.au
Berry, ColleenColleen.BERRY@austin.org.au
Brown, KerrynKez.Brown@austin.org.au
Burgess, Adele NAdele.BURGESS@austin.org.au

OrgUnit's Researchers publications
(Dept/Workgroup Publication)

Results 821-840 of 927 (Search time: 0.01 seconds).

Publication YearTitleAuthor(s)
8218-Dec-2014Taking the plunge?Siderov, Jim 
822Oct-2018Targeted therapy for metastatic colorectal cancer.Price, Timothy J; Tang, Monica; Gibbs, Peter; Haller, Daniel G; Peeters, Marc; Arnold, Dirk; Segelov, Eva; Roy, Amitesh; Tebbutt, Niall C ; Pavlakis, Nick; Karapetis, Chris; Burge, Matthew; Shapiro, Jeremy
82311-May-2009Targeting a unique EGFR epitope with monoclonal antibody 806 activates NF-kappaB and initiates tumour vascular normalization.Gan, Hui K ; Lappas, Martha; Cao, Diana; Cvrljevdic, Anna; Scott, Andrew M ; Johns, Terrance G
8242-Oct-2020Targeting and Efficacy of Novel mAb806-Antibody-Drug Conjugates in Malignant Mesothelioma.Chia, Puey Ling ; Parakh, Sagun ; Tsao, Ming-Sound; Pham, Nhu-An; Gan, Hui K ; Cao, Diana; Burvenich, Ingrid J G; Rigopoulos, Angela; Reilly, Edward B; John, Thomas ; Scott, Andrew M 
825Oct-2020Targeting Multiple EGFR Expressing Tumors with a Highly Potent Tumor-Selective Antibody Drug Conjugate.Anderson, Mark G; Falls, Hugh D; Mitten, Michael J; Oleksijew, Anatol; Vaidya, Kedar S; Boghaert, Erwin R; Gao, Wenqing; Palma, Joann P; Cao, Diana; Chia, Puey Ling ; John, Thomas ; Gan, Hui K ; Scott, Andrew M ; Reilly, Edward B
8261-Jun-2012Targeting of a conformationally exposed, tumor-specific epitope of EGFR as a strategy for cancer therapy.Gan, Hui K ; Burgess, Antony W; Clayton, Andrew H A; Scott, Andrew M 
8271-Jul-2003Targeting primary human Ph(+) B-cell precursor leukemia-engrafted SCID mice using radiolabeled anti-CD19 monoclonal antibodies.Mitchell, Paul L R ; Lee, Fook-Thean; Hall, Cathrine; Rigopoulos, Angela; Smyth, Fiona E; Hekman, Anne-Marie; van Schijndel, Gijs M; Powles, Ray; Brechbiel, Martin W; Scott, Andrew M 
828May-2023Targeting the BRAF pathway in haematological diseases.Rees, Matthew J ; Dickinson, Michael; Paterson, James; Ng, Teng F; Grigg, Andrew P ; Moore, John; Blombery, Piers; Seymour, John F
82916-Aug-2013Targeting the ERBB family in cancer: couples therapy.Tebbutt, Niall C ; Pedersen, Mikkel W; Johns, Terrance G
83012-Oct-2016Targeting the vasculature: anti-angiogenic agents for malignant mesotheliomaChia, Puey Ling ; Russell, Prudence A; Scott, Andrew M ; John, Thomas 
831Apr-2023Taxane-induced neuropathy: How serious is this problem for patients with early breast cancer?Nicolae, Robert; Uccellini, Anthony; Siderov, Jim ; Mellerick, Angela ; Wong, Vanessa ; Yeo, Belinda 
8329-Dec-2013Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial.Butts, Charles; Socinski, Mark A; Mitchell, Paul L R ; Thatcher, Nick; Havel, Libor; Krzakowski, Maciej; Nawrocki, Sergiusz; Ciuleanu, Tudor-Eliade; Bosquée, Lionel; Trigo, José Manuel; Spira, Alexander; Tremblay, Lise; Nyman, Jan; Ramlau, Rodryg; Wickart-Johansson, Gun; Ellis, Peter; Gladkov, Oleg; Pereira, José Rodrigues; Eberhardt, Wilfried Ernst Erich; Helwig, Christoph; Schröder, Andreas; Shepherd, Frances A
833Jun-2015Tecemotide in unresectable stage III non-small-cell lung cancer in the phase III START study: updated overall survival and biomarker analyses.Mitchell, Paul L R ; Thatcher, N; Socinski, M A; Wasilewska-Tesluk, E; Horwood, K; Szczesna, A; Martín, C; Ragulin, Y; Zukin, M; Helwig, C; Falk, M; Butts, C; Shepherd, F A
834Jul-2023Technique for pudendal nerve block in proctology - a video vignette.Watson, Eleanor G R; Shearer, Nicholas J W; Smart, Philip J ; Burgess, Adele N ; Proud, David M; Mohan, Helen M
835Nov-2016Temozolomide-associated liver fibrosisParakh, Sagun ; Hamid, Anis A; Cher, Lawrence M ; Gan, Hui K 
836Jul-2019Temporal Changes in Characteristics, Treatment and Outcomes of Heart Failure Patients Undergoing Percutaneous Coronary Intervention Findings from Melbourne Interventional Group Registry.Chin, Ken Lee; Tacey, Mark A ; Reid, Christopher M; Tonkin, Andrew; Hopper, Ingrid; Brennan, Angela; Andrianopoulos, Nick; Duffy, Stephen J; Clark, David J ; Ajani, Andrew E; Liew, Danny
837Aug-2016Temporal changes of EGFR mutations and T790M levels in tumour and plasma DNA following AZD9291 treatmentChia, Puey Ling ; Do, Hongdo; Morey, Adrienne; Mitchell, Paul L R ; Dobrovic, Alexander ; John, Thomas 
838Nov-2018The benefits of adding metformin to tamoxifen to protect the endometrium- a randomized placebo-controlled trial.Davis, Susan R; Robinson, Penelope J; Jane, Fiona; White, Shane ; Brown, Kristy A; Piessens, Sofie; Edwards, Andrew; McNeilage, Jane; Woinarski, Jillian; Chipman, Mitchell; Bell, Robin J
839Apr-2018The dark side of granulocyte-colony stimulating factor: a supportive therapy with potential to promote tumour progression.Yeo, Belinda ; Redfern, Andrew D; Mouchemore, Kellie A; Hamilton, John A; Anderson, Robin L 
840Jul-2019The effect of tyrosine kinase inhibitor interruption and interferon use on pregnancy outcomes and long-term disease control in chronic myeloid leukemia.Lasica, Masa; Willcox, Abbey ; Burbury, Kate; Ross, David M; Branford, Susan; Butler, Jason; Filshie, Robin; Januszewicz, Henry; Joske, David; Mills, Anthony; Simpson, David; Tam, Constantine; Taylor, Kerry; Watson, Anne-Marie; Wolf, Max; Grigg, Andrew P